Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-29 Sale | 2021-12-01 5:34 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 400 | $24.76 | $9,904 | 1,173,174 (Indirect Direct) | View |
| 2021-10-19 Sale | 2021-10-21 4:33 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 12,000 | $27.98 | $335,794 | 1,173,574 (Indirect Direct) | View |
| 2021-09-20 Sale | 2021-09-21 6:19 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 12,000 | $26.3 | $315,600 | 1,185,574 (Indirect Direct) | View |
| 2021-08-19 Sale | 2021-08-20 9:14 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 12,000 | $24.97 | $299,640 | 1,197,574 (Indirect Direct) | View |
| 2021-07-20 Sale | 2021-07-21 5:29 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 12,000 | $25.1 | $301,258 | 1,209,574 (Indirect Direct) | View |
| 2021-06-18 Sale | 2021-06-21 7:05 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 12,000 | $24.8 | $297,626 | 1,099,546 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-01 Option Award | 2022-02-03 7:10 pm | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 104,500 | $0 | 104,500 (Direct) | View |
| 2020-11-23 Conversion | 2020-11-23 4:31 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Technology Officer | 193,402 | $0 | 1,233,574 (Direct) | View |
| 2020-11-18(A) Option Award | 2020-11-20 6:42 pm | N/A 2030-11-17 | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Technology Officer | 1,076 | $0 | 1,076 (Indirect) | View |
| 2020-06-15 Option Award | 2020-11-19 6:43 pm | N/A 2030-09-11 | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Technology Officer | 550,671 | $0 | 1,447,371 (Direct) | View |
| 2020-11-18 Ownership | 2020-11-18 6:19 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Technology Officer | 0 | $0 | 1,461,433 (Direct) | View |